Journal
NUCLEIC ACIDS RESEARCH
Volume 42, Issue 6, Pages 3551-3564Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkt1358
Keywords
-
Categories
Funding
- Bayerische Forschungsstiftung (ForProtect) [AZ-862-09]
- Bill and Melinda Gates Foundation [38599]
- Bayerisches Genomforschungsnetzwerk (BayGene)
- Bayerische Forschungsstiftung (ForProtect)
Ask authors/readers for more resources
CpG dinucleotides are known to play a crucial role in regulatory domains, affecting gene expression in their natural context. Here, we demonstrate that intragenic CpG frequency and distribution impacts transgene and genomic gene expression levels in mammalian cells. As shown for the Macrophage Inflammatory Protein 1 alpha, de novo RNA synthesis correlates with the number of CpG dinucleotides, whereas RNA splicing, stability, nuclear export and translation are not affected by the sequence modification. Differences in chromatin accessibility in vivo and altered nucleosome positioning in vitro suggest that increased CpG levels destabilize the chromatin structure. Moreover, enriched CpG levels correlate with increased RNA polymerase II elongation rates in vivo. Interestingly, elevated CpG levels particularly at the 5' end of the gene promote efficient transcription. We show that this is a genome-wide feature of highly expressed genes, by identifying a domain of similar to 700 bp with high CpG content downstream of the transcription start site, correlating with high levels of transcription. We suggest that these 5' CpG domains are required to distort the chromatin structure and to increase gene activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available